Clinical trial
Early Phase I Evaluation of 64Cu-LLP2A for Imaging Multiple Myeloma
NCT03804424 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Phase I Evaluation of 64Cu-LLP2A for Imaging Multiple Myeloma
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 20, 2018
- Completion date
- October 1, 2021
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.